Perfusion System MarketSize and Trends

Over the recent past, the global perfusion system market has witnessed lucrative growth due to the increasing product launches by key players in market and the increasing number of organ transplants. For instance, according to data published by Organ Procurement and Transplantation Network (OPTN), in the U.S., over 117,000 men, women, and children were on the national transplant waiting list, as of July 2017 and 17,155 organ transplants were performed till July 2017.

Perfusion System Market Drivers

Increasing number of approvals and launches of new perfusion systems is expected to be major factor influencing growth of the perfusion system market in near future. For instance, in 2014, U.S. Food and Drugs Administration approved Xvivo Perfusion AB’s Xvivo Perfusion System (XPS) with STEEN solution, used in preserving initially unacceptable donor lungs while they are being evaluated as potentially viable transplantable organs. In February 2018, Paragonix Technologies, Inc. received approval for its new Paragonix SherpaPak Cardiac Transport System and SherpaPerfusion Cardiac Transport System in Europe. The SherpaPak Cardiac Transport System is used for the hypothermic static preservation and transport of donor hearts, and the SherpaPerfusion Cardiac Transport System consists of a single-use, disposable device for hypothermic oxygenated perfusion preservation and transport of donor hearts. The increasing investment by major key players in the market is also expected to fuel growth of the global perfusion system market in the near future. For instance, in January 2018, Miracor Medical Systems GmbH (Miracor Austria) and Miracor Medical SA (Miracor Medical) raised around US$ 26.3 Mn as part of a Series D financing round. The raised amount will be used in the development and commercialization of PiCSO Impulse System. Furthermore, the increasing demand for organ transplants is also expected to increase demand for perfusion system and increase its market growth in near future. For instance, according to the data published by National Kidney Foundation as of 2016, around 100,791 people in the U.S. are waiting for kidney transplants.

Perfusion System Market Taxonomy:

The global perfusion system market is segmented on the basis of product type, component, end user, and region:

By Product Type –